Latest clinical trials News | Page 36

Lynparza in combination with bevacizumab, and as monotherapy, demonstrates clinically meaningful survival benefit
Covid drugs persist in wastewater, may pose risk to aquatic organisms
Working to deliver world-class cancer research and care for all Tasmanians
Retina gives away signs of Alzheimer’s disease and could help with early detection
Recce Pharmaceuticals announces appointment of executive chairman
WHO and partners launch new online resource to advance STI vaccine development
Forxiga approved in China for treatment of chronic kidney disease in patients
Covid vaccine difference between men and women
Baylor College of Medicine wins COVID insurance verdict
More Aboriginal and Torres Strait Islander children have ear and hearing problems – and it’s easy to mistake for bad behaviour
World-first allergy organisations launch to improve research, clinical care and save lives
AFL legend joins fight against childhood brain cancer
Vaccination exposes latent HIV in lab studies
TGA provisionally approves Moderna bivalent Covid vaccine for use as booster dose in adults
4 researchers helping more people survive breast cancer
Monash AI model may help epilepsy patients become seizure-free
New data show Farxiga significantly lowers risk of cardiovascular death in patients with heart failure
Farxiga significantly reduced risk of cardiovascular death or worsening of heart failure
Bone Transplant Could Resolve Aging Jaw Defects
Some cancer immunotherapy treatments may damage fertility
Proposed regulatory changes for clinical trials of medical devices
Researchers identified markers of chemotherapy resistance and outcome in triple negative breast cancer
Scientists unlock potential for small cell lung cancer blood test
Immunotherapy research offers hope of improved treatment success
Linear Joondalup Early Phase Centre opens
Charcoal-based mouthwashes: literature review
Music app supporting dementia care at home
Hopes of new curative treatment for children with neuroblastoma
Symptoms of childhood ear disease and hearing loss mistaken for misbehaviour, new study finds
Centre of Excellence harnesses proteins in Australia’s flora and fauna for multiple benefits
TGA grants provisional determination for sabizabulin for treatment of Covid
World-first preventative DNA screening for cancer and heart disease risk
WHO makes new recommendations for Ebola treatments, calls for improved access
GlyNAC supplementation reverses aging hallmarks in aging humans
NetOptAwario’s new technology transforms detection of heart arrhythmias with AI and remote monitoring
Lynparza in combination with abiraterone granted Priority Review in US for patients with metastatic castration-resistant prostate
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Brain tumour bank boosts research efforts
CSIRO opens ‘missing link’ lab to developing Australian vaccine pipeline
Breakthrough in precision medicine for treatment of acute myeloid leukaemia
Dietary salt substitutes lower risk of heart attack, stroke and death
Victoria Investing In World-First mRNA Innovation Hub
How long COVID survivors are being sold next round of miracle cures
Enhertu approved in US as first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Calquence tablet formulation approved in US across current indications
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
What allegations of Alzheimer’s research fraud mean for patients